Evidence map›Paper›PMID 32119595›Full record

ArticleJCO oncology practice2020

Patient Perspectives on the Implementation of Risk-Aligned Bladder Cancer Surveillance: Systematic Evaluation Using the Tailored Implementation for Chronic Diseases Framework.

Florian R Schroeck, Amanda St Ivany, William Lowrance, Danil V Makarov, Philip P Goodney, Lisa Zubkoff

Abstract read
In one paragraph

Article in JCO oncology practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Florian R SchroeckWhite River Junction VA Medical Center, White River Junction, VT.
Amanda St IvanyDepartment of Community and Family Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH.
William LowranceSalt Lake City VA Healthcare System, Salt Lake City, UT.
Danil V MakarovNew York Harbor VA Healthcare System, New York, NY.
Philip P GoodneyWhite River Junction VA Medical Center, White River Junction, VT.
Lisa ZubkoffWhite River Junction VA Medical Center, White River Junction, VT.

Funding

Alignment of Treatment Preferences and Repair Type for Veterans with AAAI01HX001880 · VA · WHITE RIVER JUNCTION VA MEDICAL CENTER · PI GOODNEY, PHILIP P · 2018 to 2020
–
Implementing Risk-aligned Bladder Cancer SurveillanceI01HX002780 · VA · WHITE RIVER JUNCTION VA MEDICAL CENTER · PI SCHROECK, FLORIAN R · 2020 to 2023
–
HSRD VA I01 HX001880HSRD VA I01 HX002780
6 · The paper itself

Abstract

purposeMany patients living with bladder cancer do not undergo surveillance that is aligned with their risk for recurrence or progression, which exposes them to unnecessary risk and burden of procedures. To implement risk-aligned surveillance as recommended by multiple guidelines, we need to understand patient-, provider-, and system-level factors contributing to the delivery of risk-aligned surveillance. In this study, we sought to systematically assess patient-level factors. PARTICIPANTS AND

methodsGuided by the Tailored Implementation for Chronic Diseases framework, we conducted semistructured interviews with 22 patients with bladder cancer undergoing surveillance cystoscopy procedures at three facilities within the Department of Veterans Affairs. Patients were sampled using quantitative data on bladder cancer risk category (low

resultsParticipants included seven low-risk and 15 high-risk patients; 10 underwent risk-aligned surveillance and 12 did not. In mixed-methods analyses, perception of risk appropriately differed by risk but not by surveillance category. Participants understood the recommended surveillance schedule according to their risk category. Participants emphatically expressed that adhering to providers' recommendations is prudent; intentions to adhere did not vary across risk and surveillance categories.

conclusionParticipants intended to adhere to providers' recommendations and strongly endorsed the importance of adherence. These findings suggest implementation strategies to improve risk-aligned surveillance may be most effective when targeting provider- and system-level factors rather than patient-level factors.

Indexed as

Urinary Bladder NeoplasmsChronic DiseaseCystoscopyHumansNeoplasm Recurrence, Local

Identifiers

PMID32119595
PMCPMC10841578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.